核医学在冠状动脉微血管疾病诊断与危险分层中的作用
本文阐述冠状动脉血流储备(CFR)正电子发射断层扫描/计算机断层扫描(PET/CT)在冠状动脉微血管疾病(CMD)诊断、危险分层及疗效监测中的作用,指出非阻塞性冠状动脉缺血(INOCA)患者CFR降低可识别高危人群,而单光子发射断层扫描(SPECT)测量CFR可行且经验证。
要点
- PET/CT测量的CFR在CMD诊断中具重要作用,并有助于危险分层。
- 约50%接受血管造影的心绞痛患者为非阻塞性CAD,INOCA预后不良。
- INOCA患者CFR降低可识别可能从CMD特异性管理策略中获益的高危组。
核心结论
- CFR测量可增进对CMD在CAD及其他心血管疾病症状与预后中作用的理解。
- INOCA患者CFR降低可识别可能从CMD特异性管理策略中获益的高危人群。
- CMD患者可通过CFR降低被识别并选择特异性治疗。
研究设计与样本
- 综述,聚焦核医学在CMD诊断与危险分层中的作用。
主要发现
- CAD、非缺血性心肌病和心力衰竭患者的CMD导致症状并带来更差预后。
- 因心绞痛接受血管造影的患者中,非阻塞性CAD患病率已增至约50%。
- INOCA可因CMD、心外膜血管痉挛或弥漫性非阻塞性CAD而出现缺血。
- PET/CT测量CFR具有极好的准确性和重复性,但受成本和可及性限制。
- SPECT测量CFR可行且经验证,可提高CFR的可及性和使用。
局限性
- PET/CT测量CFR的应用受成本和可及性限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Coronary flow reserve (CFR) with positron emission tomography/computed tomography (PET/CT) has an important role in the diagnosis of coronary microvascular disease (CMD), aids risk stratification and may be useful in monitoring therapy. CMD contributes to symptoms and a worse prognosis in patients with coronary artery disease (CAD), nonischemic cardiomyopathies, and heart failure. CFR measurements may improve our understanding of the role of CMD in symptoms and prognosis in CAD and other cardiovascular diseases. The clinical presentation of CAD has changed. The prevalence of nonobstructive CAD has increased to about 50% of patients with angina undergoing angiography. Ischemia with nonobstructive arteries (INOCA) is recognized as an important cause of symptoms and has an adverse prognosis. Patients with INOCA may have ischemia due to CMD, epicardial vasospasm or diffuse nonobstructive CAD. Reduced CFR in patients with INOCA identifies a high-risk group that may benefit from management strategies specific for CMD. Although measurement of CFR by PET/CT has excellent accuracy and repeatability, use is limited by cost and availability. CFR measurement with single-photon emission tomography (SPECT) is feasible, validated, and would increase availability and use of CFR. Patients with CMD can be identified by reduced CFR and selected for specific therapies.
引用
- Ruddy TD, Tavoosi A, Taqueti VR, et al. Role of nuclear cardiology in diagnosis and risk stratification of coronary microvascular disease. J Nucl Cardiol. 2022. PMID: 35851643. doi:10.1007/s12350-022-03051-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。